Enrico Attardi
@enrico_attardi
Followers
154
Following
348
Media
8
Statuses
68
MD PhD, hematologist at @unitorvergata @StJude | germline predisposition to #BMF #MDSsm and secondary #AMLsm
Memphis, TN
Joined January 2023
Finally published!!!✨ Clinical exome sequencing to evaluate germline genetic predisposition in the “no man’s land” of young adult MDS cases @Hemasphere_EHA #MDSsm open access here: https://t.co/YtAr4P7NrZ
7
14
32
Check out our new review on secondary and therapy-related AML🩸 Out in @SeminarsinHematology Secondary and therapy-related acute myeloid leukemias: Overlapping fea... https://t.co/wcN6ZyyS7E
@enrico_attardi @MariaTeresaVoso
0
1
1
Antiaging for Ph-like ALL: targeting senescence https://t.co/6uwhbQhMXr I really enjoyed writing this Commentary on targeting senescent stem cell–like subpopulations in preclinical models of Ph-like ALL by dual JAK/STAT and BCL-2 inhibition. Out today in @BloodJournal #leukemia
0
3
17
#ASH24 | @IlariaIacobucc1 of @StJude discusses myeloid mutations in ALL and provides insight into their role in identifying those at risk of secondary malignancies. 🧬🩸 Click here to watch: 👉 https://t.co/b2nybNdcIL
#ALLsm #Leusm #CaGenome #Leukemia #HemOnc @ASH_hematology
vjhemonc.com
Ilaria Iacobucci, PhD, St. Jude Children's Research Hospital, Memphis, TN, comments on the presence of myeloid mutations in acute lymphoblastic leukemia (ALL). She highlights that these mutations can...
0
1
6
Announcement!!! 📣📣📣 We are looking for contributions for a Research Topic on de novo and secondary AML in @FrontiersIn you can read about the project here: https://t.co/HOedl5Tq04
#AMLsm #MDSsm
0
2
6
Our "Germline Predisposition to MDS and AML" chapter is finally published in Springer's Book "Acute Myeloid Leukemia in Children." It was a pleasure co-authoring this chapter! https://t.co/ZYD1XOisVG
@StJude
0
2
9
Exploring the erythroid world in LR-MDS! Congrats @vs_mds_unit ! 👏👏👏 #MDSsm
Finally out 🤩!! LR-MDS ESA response prediction beyond sEPO with flow cytometry of erythroid precursors and molecular features. Lack of predictors is a unmet need with approval of new drugs!! #MDSs #anemia @vs_mds_unit @Santin13Valeria @enrico_attardi
https://t.co/BXzwJrJXGM
1
0
2
🎙️ New podcast out! Join Prof Maria Teresa Voso for insights on #MDS diagnosis & management. Hear about latest advancements in #PrecisionMedicine for MDS and the importance of personalized approaches in improving patient outcomes. Find it on #EHACampus: https://t.co/XexvPmkdzu
1
2
12
I am proud to present my lab’s first research paper, published online in @LeukemiaJnl today! Check it out https://t.co/T3TNpQEru2 Congrats to first author Emily Stepanchick!
5
8
40
Fueled by more recent research helping identify and treat Diamond Blackfan anemia syndrome, @MarrowGenes and collaborators helmed a multinational effort to create new DBA guidelines for treatment. @TheLancetHaem
thelancet.com
Diamond-Blackfan anaemia (DBA), first described over 80 years ago, is a congenital disorder of erythropoiesis with a predilection for birth defects and cancer. Despite scientific advances, this...
0
1
5
Thanks @BCD_AACR for the opportunity to write a “In the Spotlight” and congratulations to @CanerSaygin and co-authors for the beautiful paper! Check it out to know more about the role of “myeloid” mutations and clonal hematopoiesis in adult ALL
aacrjournals.org
Summary:. In Blood Cancer Discovery, Saygin and colleagues report that somatic variants that are recurrent in myeloid malignancies can also occur with high frequency (16%) in adult acute lymphoblas...
1
4
27
@marrowgenes offers a brilliant overview of GATA2 and SAMD9/L syndromes at the Kyoto MDSR 2024🇯🇵 meeting @MDSFoundation
0
2
15
Exploring the intricate dance between #CH and autoimmunity. Our latest review article with @rheumrob & @VisconteValeria shedding light on the complex interplay of genetics and inflammation. #CHIP #VEXAS #Autoimmunity Clonal hematopoiesis and autoimmunity https://t.co/JJHJZvCl7p
3
11
42
The family of Clonal Hematopoiesis grows🌱: take a look at our review about CHIPI (clonal hematopoiesis in predisposed individuals), now In Press in Seminars in Hematology @marrowgenes
https://t.co/LorPqcI2uO
0
11
26
Call for abstracts📣📣📣 APL symposium in Rome, Italy🇮🇹 deadline is January 17th @EHA_Hematology @young_eha @TheEBMT @ASH_hematology @Young_LABMT @ASCO amazing opportunity to present your data and enjoy Rome!
0
6
36
CONGRESS | #ASH23 Enrico Attardi @enrico_attardi @unitorvergata @StJude dissects ICC “diagnostic qualifiers”, using a cohort of 155 patients with #AML progressing from #MDS or MDS/MPN (sAML) and 65 patients with tAML, and comparing to 233 patients with de novo MDS-related AML
0
4
5
Bravissimo @enrico_attardi presenting data on sAML and the intertwine on new and old diagnostic classifications at #ASH23
1
4
22
We are young, we ❤️ hematology, transplant and cellular therapy! @TheEBMT_Trainee at #ASH23 @ASH_hematology
3
16
106
Long-term follow-up and disease monitoring in a NRAS mutated case of Ras-associated autoimmune leukoproliferative disorder https://t.co/lsT6AuTUdY
#leusm @enrico_attardi
0
3
4